Free Trial
→ The Iran War Just Broke the Gold Market (From Behind the Markets) (Ad)tc pixel Free AMBI Stock Alerts

This company has been marked as potentially delisted and may not be actively trading.

Ambit Biosciences (AMBI) Competitors

Ambit Biosciences logo
Compare

AMBI vs. BOOM, HURC, LAKE, SSTI, and RSSS

Should you be buying Ambit Biosciences stock or one of its competitors? The main competitors of Ambit Biosciences include DMC Global (BOOM), Hurco Companies (HURC), Lakeland Industries (LAKE), SoundThinking (SSTI), and Research Solutions (RSSS). These companies are all part of the "industrials" sector.

How does Ambit Biosciences compare to DMC Global?

Ambit Biosciences (NASDAQ:AMBI) and DMC Global (NASDAQ:BOOM) are both small-cap industrials companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, analyst recommendations, dividends, media sentiment, earnings, institutional ownership and valuation.

Ambit Biosciences has a beta of 0.55, suggesting that its share price is 45% less volatile than the S&P 500. Comparatively, DMC Global has a beta of 1.71, suggesting that its share price is 71% more volatile than the S&P 500.

26.8% of Ambit Biosciences shares are owned by institutional investors. Comparatively, 77.6% of DMC Global shares are owned by institutional investors. 52.0% of Ambit Biosciences shares are owned by company insiders. Comparatively, 7.1% of DMC Global shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Ambit Biosciences has higher earnings, but lower revenue than DMC Global.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ambit Biosciences$518.81M0.06$3.44MN/AN/A
DMC Global$609.84M0.26-$13.45M-$1.27N/A

Ambit Biosciences has a net margin of 0.00% compared to DMC Global's net margin of -4.28%. Ambit Biosciences' return on equity of 0.00% beat DMC Global's return on equity.

Company Net Margins Return on Equity Return on Assets
Ambit BiosciencesN/A N/A N/A
DMC Global -4.28%-6.02%-2.30%

DMC Global has a consensus price target of $8.50, indicating a potential upside of 11.26%. Given DMC Global's stronger consensus rating and higher possible upside, analysts clearly believe DMC Global is more favorable than Ambit Biosciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ambit Biosciences
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
DMC Global
1 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

In the previous week, DMC Global had 12 more articles in the media than Ambit Biosciences. MarketBeat recorded 12 mentions for DMC Global and 0 mentions for Ambit Biosciences. DMC Global's average media sentiment score of 0.26 beat Ambit Biosciences' score of 0.00 indicating that DMC Global is being referred to more favorably in the news media.

Company Overall Sentiment
Ambit Biosciences Neutral
DMC Global Neutral

Summary

DMC Global beats Ambit Biosciences on 9 of the 14 factors compared between the two stocks.

How does Ambit Biosciences compare to Hurco Companies?

Hurco Companies (NASDAQ:HURC) and Ambit Biosciences (NASDAQ:AMBI) are both small-cap industrials companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, dividends, valuation, earnings, profitability and analyst recommendations.

Ambit Biosciences has a net margin of 0.00% compared to Hurco Companies' net margin of -8.15%. Ambit Biosciences' return on equity of 0.00% beat Hurco Companies' return on equity.

Company Net Margins Return on Equity Return on Assets
Hurco Companies-8.15% -7.13% -5.40%
Ambit Biosciences N/A N/A N/A

In the previous week, Hurco Companies had 1 more articles in the media than Ambit Biosciences. MarketBeat recorded 1 mentions for Hurco Companies and 0 mentions for Ambit Biosciences. Hurco Companies' average media sentiment score of 0.75 beat Ambit Biosciences' score of 0.00 indicating that Hurco Companies is being referred to more favorably in the media.

Company Overall Sentiment
Hurco Companies Positive
Ambit Biosciences Neutral

Ambit Biosciences has higher revenue and earnings than Hurco Companies.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hurco Companies$178.55M0.62-$15.12M-$2.21N/A
Ambit Biosciences$518.81M0.06$3.44MN/AN/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hurco Companies
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Ambit Biosciences
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Hurco Companies has a beta of 0.75, suggesting that its share price is 25% less volatile than the S&P 500. Comparatively, Ambit Biosciences has a beta of 0.55, suggesting that its share price is 45% less volatile than the S&P 500.

74.4% of Hurco Companies shares are held by institutional investors. Comparatively, 26.8% of Ambit Biosciences shares are held by institutional investors. 9.9% of Hurco Companies shares are held by insiders. Comparatively, 52.0% of Ambit Biosciences shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Hurco Companies and Ambit Biosciences tied by winning 6 of the 12 factors compared between the two stocks.

How does Ambit Biosciences compare to Lakeland Industries?

Lakeland Industries (NASDAQ:LAKE) and Ambit Biosciences (NASDAQ:AMBI) are both small-cap industrials companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, dividends, profitability, earnings, analyst recommendations, risk and valuation.

Ambit Biosciences has a net margin of 0.00% compared to Lakeland Industries' net margin of -13.14%. Ambit Biosciences' return on equity of 0.00% beat Lakeland Industries' return on equity.

Company Net Margins Return on Equity Return on Assets
Lakeland Industries-13.14% -9.57% -6.06%
Ambit Biosciences N/A N/A N/A

In the previous week, Lakeland Industries had 1 more articles in the media than Ambit Biosciences. MarketBeat recorded 1 mentions for Lakeland Industries and 0 mentions for Ambit Biosciences. Lakeland Industries' average media sentiment score of 0.00 equaled Ambit Biosciences'average media sentiment score.

Company Overall Sentiment
Lakeland Industries Neutral
Ambit Biosciences Neutral

Ambit Biosciences has higher revenue and earnings than Lakeland Industries.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Lakeland Industries$192.65M0.47-$25.31M-$2.58N/A
Ambit Biosciences$518.81M0.06$3.44MN/AN/A

Lakeland Industries presently has a consensus target price of $15.20, suggesting a potential upside of 64.50%. Given Lakeland Industries' stronger consensus rating and higher possible upside, research analysts clearly believe Lakeland Industries is more favorable than Ambit Biosciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Lakeland Industries
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
Ambit Biosciences
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Lakeland Industries has a beta of 1.45, suggesting that its stock price is 45% more volatile than the S&P 500. Comparatively, Ambit Biosciences has a beta of 0.55, suggesting that its stock price is 45% less volatile than the S&P 500.

71.7% of Lakeland Industries shares are held by institutional investors. Comparatively, 26.8% of Ambit Biosciences shares are held by institutional investors. 1.9% of Lakeland Industries shares are held by insiders. Comparatively, 52.0% of Ambit Biosciences shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Lakeland Industries beats Ambit Biosciences on 7 of the 13 factors compared between the two stocks.

How does Ambit Biosciences compare to SoundThinking?

SoundThinking (NASDAQ:SSTI) and Ambit Biosciences (NASDAQ:AMBI) are both small-cap industrials companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, dividends, profitability, earnings, analyst recommendations, risk and valuation.

Ambit Biosciences has a net margin of 0.00% compared to SoundThinking's net margin of -9.05%. Ambit Biosciences' return on equity of 0.00% beat SoundThinking's return on equity.

Company Net Margins Return on Equity Return on Assets
SoundThinking-9.05% -12.81% -6.96%
Ambit Biosciences N/A N/A N/A

In the previous week, Ambit Biosciences' average media sentiment score of 0.00 beat SoundThinking's score of -1.00 indicating that Ambit Biosciences is being referred to more favorably in the news media.

Company Overall Sentiment
SoundThinking Negative
Ambit Biosciences Neutral

Ambit Biosciences has higher revenue and earnings than SoundThinking.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SoundThinking$104.13M0.86-$9.42M-$0.74N/A
Ambit Biosciences$518.81M0.06$3.44MN/AN/A

SoundThinking presently has a consensus target price of $14.00, suggesting a potential upside of 101.44%. Given SoundThinking's stronger consensus rating and higher possible upside, research analysts clearly believe SoundThinking is more favorable than Ambit Biosciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SoundThinking
1 Sell rating(s)
3 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.29
Ambit Biosciences
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

SoundThinking has a beta of 1.17, suggesting that its stock price is 17% more volatile than the S&P 500. Comparatively, Ambit Biosciences has a beta of 0.55, suggesting that its stock price is 45% less volatile than the S&P 500.

60.7% of SoundThinking shares are held by institutional investors. Comparatively, 26.8% of Ambit Biosciences shares are held by institutional investors. 10.4% of SoundThinking shares are held by insiders. Comparatively, 52.0% of Ambit Biosciences shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Ambit Biosciences beats SoundThinking on 7 of the 13 factors compared between the two stocks.

How does Ambit Biosciences compare to Research Solutions?

Ambit Biosciences (NASDAQ:AMBI) and Research Solutions (NASDAQ:RSSS) are both small-cap industrials companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, profitability, earnings, dividends, media sentiment, valuation, risk and analyst recommendations.

Ambit Biosciences has higher revenue and earnings than Research Solutions.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ambit Biosciences$518.81M0.06$3.44MN/AN/A
Research Solutions$49.06M1.72$1.27M$0.1221.33

26.8% of Ambit Biosciences shares are owned by institutional investors. Comparatively, 33.6% of Research Solutions shares are owned by institutional investors. 52.0% of Ambit Biosciences shares are owned by company insiders. Comparatively, 10.9% of Research Solutions shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Research Solutions has a net margin of 7.87% compared to Ambit Biosciences' net margin of 0.00%. Research Solutions' return on equity of 26.71% beat Ambit Biosciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Ambit BiosciencesN/A N/A N/A
Research Solutions 7.87%26.71%8.55%

In the previous week, Research Solutions had 2 more articles in the media than Ambit Biosciences. MarketBeat recorded 2 mentions for Research Solutions and 0 mentions for Ambit Biosciences. Research Solutions' average media sentiment score of 0.34 beat Ambit Biosciences' score of 0.00 indicating that Research Solutions is being referred to more favorably in the news media.

Company Overall Sentiment
Ambit Biosciences Neutral
Research Solutions Neutral

Research Solutions has a consensus target price of $5.00, indicating a potential upside of 95.31%. Given Research Solutions' stronger consensus rating and higher possible upside, analysts plainly believe Research Solutions is more favorable than Ambit Biosciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ambit Biosciences
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Research Solutions
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33

Ambit Biosciences has a beta of 0.55, suggesting that its stock price is 45% less volatile than the S&P 500. Comparatively, Research Solutions has a beta of 0.82, suggesting that its stock price is 18% less volatile than the S&P 500.

Summary

Research Solutions beats Ambit Biosciences on 11 of the 14 factors compared between the two stocks.

Get Ambit Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for AMBI and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AMBI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AMBI vs. The Competition

Export
MetricAmbit BiosciencesSanitary services IndustryIndustrials SectorNASDAQ Exchange
Market Cap$29.91M$8.01M$9.18B$11.76B
Dividend YieldN/AN/A3.57%5.26%
P/E RatioN/AN/A25.1927.07
Price / Sales0.06N/A4,997.8673.40
Price / Cash6.40N/A27.4453.90
Price / Book0.11307.004.726.69
Net Income$3.44M-$600K$792.42M$332.64M

Ambit Biosciences Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AMBI
Ambit Biosciences
N/A$0.54
flat		N/AN/A$29.91M$518.81MN/A7,000
BOOM
DMC Global
2.4005 of 5 stars		$6.41
+13.5%		$8.50
+32.6%		+9.3%$115.68M$609.84MN/A1,500
HURC
Hurco Companies
0.5458 of 5 stars		$16.45
+1.0%		N/A+15.9%$105.01M$175.01MN/A740
LAKE
Lakeland Industries
3.0085 of 5 stars		$10.05
-1.0%		$15.20
+51.2%		-44.0%$99.84M$192.65MN/A2,600
SSTI
SoundThinking
2.355 of 5 stars		$6.71
+0.8%		$14.00
+108.6%		-54.5%$86.27M$104.13MN/A213

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:AMBI) was last updated on 5/6/2026 by MarketBeat.com Staff.
From Our Partners
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
I’m sounding the alarm
Meta is cutting 10% of its workforce. Microsoft offered voluntary retirement to 7% of U.S. employees. Oracle, ...
Porter & Company | Sponsoredtc pixel
How to collect $1,170/month from silver
There is a silver fund paying up to 20% in yearly distributions - no mining stocks, no options required. The s...
Investors Alley | Sponsoredtc pixel
Satellite Images Spot Potential $10 Trillion Discovery
'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...
Altimetry | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Did you miss The Dark AI Summit?
Over 55,000 people attended Jeff Brown's Dark AI Summit, where he revealed a private AI company he believes ho...
Brownstone Research | Sponsoredtc pixel
Iran War Update: Trump’s Hand-Written Letter Reveals What Comes Next
Jim Rickards has uncovered what he believes is Trump's economic plan, with a key trigger date of May 15. The F...
Paradigm Press | Sponsoredtc pixel
Elon's new "super startup"
Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...
Banyan Hill Publishing | Sponsoredtc pixel